Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase NA 7Phase 2 6Phase EARLY_PHASE1 2Phase 1/2 2Phase 4 1Phase 3 1Phase 2/3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Pancreatic Neoplasms 76Colorectal Neoplasms 55Carcinoma, Hepatocellular 51Stomach Neoplasms 34Colonic Neoplasms 26Breast Neoplasms 23Lung Neoplasms 15Rectal Neoplasms 12Ovarian Neoplasms 12Liver Neoplasms 12Sarcoma 11Gastrointestinal Neoplasms 11Neoplasms 10Esophageal Neoplasms 10Barrett Esophagus 9Melanoma 7Head and Neck Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Prostatic Neoplasms 6Cholangiocarcinoma 6Carcinoma, Renal Cell 5Neoplasm Metastasis 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Brain Neoplasms 4Uterine Cervical Neoplasms 3Pancreatic Ductal Adenocarcinoma 3Osteosarcoma 3Esophageal Squamous Cell Carcinoma 3Disease 3Digestive System Neoplasms 3

Interventions

Specimen Handling 1Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Urogenital Neoplasms × Gastrointestinal × Clear all
NCT07389525 2026-04-24

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

Indiana University

Phase EARLY_PHASE1 Not yet recruiting
80 enrolled
DermatologicGastrointestinalSarcoma

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

NCT04067960 2024-08-14

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Mayo Clinic

Phase EARLY_PHASE1 Completed
197 enrolled
CNSGastrointestinalGenitourinaryGynecologic

Brain Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡